Prolong Pharmaceuticals LLC
Prolong Pharmaceuticals is a pharmaceuticals manufacturer.
Based in NJ
AI Overview
With $120K in lobbying spend across 12 quarterly filings, Prolong Pharmaceuticals LLC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2020.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $40K |
| 2019 | $40K |
| 2020 | $40K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Prolong Pharmaceuticals LLC disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Health Issues
FY17 & FY18 funding for Blood Disorders Programs, TBI & Transplantation
Access to treatments for people with Sickle Cell Disease, treatment center model
Sickle Cell Legislation
Engaging NIH/CDC on hematology issues
Research at NHLBI & NIDDK
Cures Implementation &
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.